You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in United Therapeutics Corporation v. Liquidia Technologies, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2022-10-06 15 U.S. Patent No. 8,497,393 (Ex. 1004, "the ' 393 patent") is aparent of …claims for athird patent, the newly issued U.S. Patent No. 10,716,793 (the "`793 patent"). (D.I…Third, Patent Owner's reliance on claim 5of the ' 066 patent is unavailing. Patent Owner… Patent 9,604,901132 Patent Owner begins by contending that the ' 901 patent "…product from launching based solely on a patent—the ʼ793 patent—the PTAB has deemed unpatentable. The External link to document
2023-01-23 30 U.S. Patent No. 8,497,393793 patent U.S. Patent No. 10,716,793 ’793 FWD … Full Term ’066 patent U.S. Patent No. 9,593,066393 patent … 6, 8, 9 patent Asserted claims of the ’793 Claims 1, 4, 6, 7, 8 patent Asserted Patents …’793 Patent Claims Lack Written Description......... 12 D. The ’793 Patent Claims… Decision in IPR2021-00406 ’901 patent U.S. Patent No. 9,604,901 ʼ901 FWD External link to document
2023-02-01 32 U.S. Patent No. 8,497,393793 patent U.S. Patent No. 10,716,793 ’793 FWD … Full Term ’066 patent U.S. Patent No. 9,593,066393 patent … 6, 8, 9 patent Asserted claims of the ’793 Claims 1, 4, 6, 7, 8 patent Asserted Patents …’793 Patent Claims Lack Written Description......... 11 D. The ’793 Patent Claims… Decision in IPR2021-00406 ’901 patent U.S. Patent No. 9,604,901 ʼ901 FWD External link to document
2023-02-13 36 GLOSSARY ’066 Patent U.S. Patent No. 9,593,066 ’393 Patent U.S. Patent No. 8,497,393… Patent Trial and Appeal Board PTO U.S. Patent and Trademark Office… requirements of patentability,” id., including the ordinary “presumption of patent validity” enjoyed…product-by-process claims patentable. That is how product-by-process patents work. Liquidia also…claims 6 and 8 of the ’066 Patent and that claims 1, 2, 3, and 6 of the ’066 Patent are invalid as anticipated External link to document
2023-08-23 65 Liquidia and (2) claims 1–3 of U.S. Patent 9,593,066 (“the ’066 patent”) are invalid as anticipated, but…UTC”) U.S. Patent No. 10,716,793 (the “ʼ793 patent”) was Liquidia’s IPR of the ʼ793 patent. The district…induce another’s infringement of a patent deemed, under proper Patent Office procedures, invalid. Appx31145…infringe pertains to a patent that is shown to be invalid, there is no patent to be infringed.” Id. …infringer can . . . prove that patent in suit is invalid[,]” because “if the patent is indeed invalid, and shown External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.